{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T20:22:00Z","timestamp":1793823720080,"version":"4.6.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing","doi-asserted-by":"publisher","award":["Grant No. cstc2020jcyj-msxmX0569"],"award-info":[{"award-number":["Grant No. cstc2020jcyj-msxmX0569"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Basic Research and Frontier Exploration Key Project of Chongqing Science and Technology Commission","award":["Grant No. cstc2019jcyj-zdxmX0020"],"award-info":[{"award-number":["Grant No. cstc2019jcyj-zdxmX0020"]}]},{"name":"High level Medical Reserved Personnel Training Project of Chongqing, CQMU Program for Youth Innovation in Future Medicine","award":["W0026"],"award-info":[{"award-number":["W0026"]}]},{"name":"Kuanren Talents Program of the Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University","award":["KR2019G001"],"award-info":[{"award-number":["KR2019G001"]}]},{"name":"Chongqing Science and Health Joint Medical Research Project Young and Middle-aged High Level Talent Project","award":["2020GDRC011"],"award-info":[{"award-number":["2020GDRC011"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["Grant No.82171946"],"award-info":[{"award-number":["Grant No.82171946"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Basic Research and Frontier Exploration Project of Yuzhong District, Chongqing","award":["20190112"],"award-info":[{"award-number":["20190112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Combined therapy based on the effects of cascade reactions of nanoplatforms to combat specific solid tumor microenvironments is considered a cancer treatment strategy with transformative clinical value. Unfortunately, an insufficient O<jats:sub>2<\/jats:sub> supply and the lack of a visual indication hinder further applications of most nanoplatforms for solid tumor therapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A visualizable nanoplatform of liposome nanoparticles loaded with GOD, H(Gd), and PFP and grafted with the peptide tLyP-1, named <jats:sub>tLyP-1<\/jats:sub>H(Gd)-GOD@PFP, was constructed. The double-domain peptide tLyP-1 was used to specifically target and penetrate the tumor cells; then, US imaging, starvation therapy and sonodynamic therapy (SDT) were then achieved by the ultrasound (US)-activated cavitation effect under the guidance of MR\/PA imaging. GOD not only deprived the glucose for starvation therapy but also produced H<jats:sub>2<\/jats:sub>O<jats:sub>2<\/jats:sub>, which in coordination with\u00a0<jats:sup>1<\/jats:sup>O<jats:sub>2<\/jats:sub> produced by H(Gd), enable the effects of SDT to achieve a synergistic therapeutic effect. Moreover, the synergistic therapy was enhanced by O<jats:sub>2<\/jats:sub> from PFP and low-intensity focused ultrasound (LIFU)-accelerated redox effects of the GOD. The present study demonstrated that the nanoplatform could generate a 3.3-fold increase in ROS, produce a 1.5-fold increase in the maximum rate of redox reactions and a 2.3-fold increase in the O<jats:sub>2<\/jats:sub> supply in vitro<jats:italic>,<\/jats:italic> and achieve significant tumor inhibition in vivo.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We present a visualizable nanoplatform with tumor-penetrating ability that can be unlocked by US to overcome the current treatment problems by improving the controllability of the O<jats:sub>2<\/jats:sub> supply, which ultimately synergistically enhanced cascade therapy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12951-023-01765-x","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T16:02:55Z","timestamp":1674662575000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Tumor-penetrating nanoplatform with ultrasound \u201cunlocking\u201d for cascade synergistic therapy and visual feedback under hypoxia"],"prefix":"10.1186","volume":"21","author":[{"given":"Zhuoyan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junrui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanli","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianli","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"1765_CR1","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ccell.2018.02.008","volume":"33","author":"AE Allen","year":"2018","unstructured":"Allen AE, Locasale JW. Glucose metabolism in cancer: the saga of pyruvate kinase continues. Cancer Cell. 2018;33:337\u20139.","journal-title":"Cancer Cell"},{"key":"1765_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/nrc.2016.77","volume":"16","author":"N Hay","year":"2016","unstructured":"Hay N. Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy? Nat Rev Cancer. 2016;16:635\u201349.","journal-title":"Nat Rev Cancer"},{"key":"1765_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/nrd2803","volume":"8","author":"D Trachootham","year":"2009","unstructured":"Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov. 2009;8:579\u201391.","journal-title":"Nat Rev Drug Discov"},{"key":"1765_CR4","doi-asserted-by":"publisher","first-page":"4881","DOI":"10.1021\/acs.chemrev.8b00626","volume":"119","author":"B Yang","year":"2019","unstructured":"Yang B, Chen Y, Shi J. Reactive oxygen species (ROS)-based nanomedicine. Chem Rev. 2019;119:4881\u2013985.","journal-title":"Chem Rev"},{"key":"1765_CR5","doi-asserted-by":"publisher","first-page":"6454","DOI":"10.1039\/C7CS00891K","volume":"47","author":"LH Fu","year":"2018","unstructured":"Fu LH, Qi C, Lin J, Huang P. Catalytic chemistry of glucose oxidase in cancer diagnosis and treatment. Chem Soc Rev. 2018;47:6454\u201372.","journal-title":"Chem Soc Rev"},{"key":"1765_CR6","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.1038\/s41467-022-30436-y","volume":"13","author":"L Dai","year":"2022","unstructured":"Dai L, Yao M, Fu Z, Li X, Zheng X, Meng S, Yuan Z, Cai K, Yang H, Zhao Y. Multifunctional metal-organic framework-based nanoreactor for starvation\/oxidation improved indoleamine 2,3-dioxygenase-blockade tumor immunotherapy. Nat Commun. 2022;13:2688.","journal-title":"Nat Commun"},{"key":"1765_CR7","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1039\/C7CS00471K","volume":"47","author":"H Lin","year":"2018","unstructured":"Lin H, Chen Y, Shi J. Nanoparticle-triggered in situ catalytic chemical reactions for tumour-specific therapy. Chem Soc Rev. 2018;47:1938\u201358.","journal-title":"Chem Soc Rev"},{"key":"1765_CR8","doi-asserted-by":"publisher","first-page":"121428","DOI":"10.1016\/j.biomaterials.2022.121428","volume":"283","author":"F Shen","year":"2022","unstructured":"Shen F, Tao D, Peng R, He Y, Liu Z, Ji J, Feng L. Immunogenic nanomedicine based on GSH-responsive nanoscale covalent organic polymers for chemo-sonodynamic therapy. Biomaterials. 2022;283:121428.","journal-title":"Biomaterials"},{"key":"1765_CR9","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.bioactmat.2021.06.021","volume":"8","author":"G Li","year":"2022","unstructured":"Li G, Zhong X, Wang X, Gong F, Lei H, Zhou Y, Li C, Xiao Z, Ren G, Zhang L, et al. Titanium carbide nanosheets with defect structure for photothermal-enhanced sonodynamic therapy. Bioact Mater. 2022;8:409\u201319.","journal-title":"Bioact Mater"},{"issue":"1694\u20131708","key":"1765_CR10","first-page":"e1619","volume":"185","author":"P Baldominos","year":"2022","unstructured":"Baldominos P, Barbera-Mourelle A, Barreiro O, Huang Y, Wight A, Cho JW, Zhao X, Estivill G, Adam I, Sanchez X, et al. Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche. Cell. 2022;185(1694\u20131708):e1619.","journal-title":"Cell"},{"key":"1765_CR11","doi-asserted-by":"publisher","first-page":"e2203734","DOI":"10.1002\/adma.202203734","volume":"34","author":"Y Hua","year":"2022","unstructured":"Hua Y, Huang JH, Shao ZH, Luo XM, Wang ZY, Liu JQ, Zhao X, Chen X, Zang SQ. Composition-dependent enzyme mimicking activity and radiosensitizing effect of bimetallic clusters to modulate tumor hypoxia for enhanced cancer therapy. Adv Mater. 2022;34:e2203734.","journal-title":"Adv Mater"},{"key":"1765_CR12","doi-asserted-by":"publisher","first-page":"121495","DOI":"10.1016\/j.biomaterials.2022.121495","volume":"284","author":"F Nan","year":"2022","unstructured":"Nan F, Jia Q, Xue X, Wang S, Liu W, Wang J, Ge J, Wang P. Iron phthalocyanine-derived nanozyme as dual reactive oxygen species generation accelerator for photothermally enhanced tumor catalytic therapy. Biomaterials. 2022;284:121495.","journal-title":"Biomaterials"},{"key":"1765_CR13","doi-asserted-by":"publisher","first-page":"1902137","DOI":"10.1002\/advs.201902137","volume":"6","author":"S Gao","year":"2019","unstructured":"Gao S, Jin Y, Ge K, Li Z, Liu H, Dai X, Zhang Y, Chen S, Liang X, Zhang J. Self-supply of O2 and H2O2 by a nanocatalytic medicine to enhance combined chemo\/chemodynamic therapy. Adv Sci (Weinh). 2019;6:1902137.","journal-title":"Adv Sci (Weinh)"},{"key":"1765_CR14","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.apsb.2020.01.004","volume":"10","author":"Y Sun","year":"2020","unstructured":"Sun Y, Zhao D, Wang G, Wang Y, Cao L, Sun J, Jiang Q, He Z. Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development. Acta Pharm Sin B. 2020;10:1382\u201396.","journal-title":"Acta Pharm Sin B"},{"key":"1765_CR15","doi-asserted-by":"publisher","first-page":"50275","DOI":"10.1021\/acsami.0c14822","volume":"12","author":"MMT Jansman","year":"2020","unstructured":"Jansman MMT, Liu X, Kempen P, Clergeaud G, Andresen TL, Thulstrup PW, Hosta-Rigau L. Hemoglobin-based oxygen carriers incorporating nanozymes for the depletion of reactive oxygen species. ACS Appl Mater Interfaces. 2020;12:50275\u201386.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1765_CR16","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c01407","author":"M Sun","year":"2022","unstructured":"Sun M, Yue T, Wang C, Fan Z, Gazit E, Du J. Ultrasound-responsive peptide nanogels to balance conflicting requirements for deep tumor penetration and prolonged blood circulation. ACS Nano. 2022. https:\/\/doi.org\/10.1021\/acsnano.2c01407.","journal-title":"ACS Nano"},{"key":"1765_CR17","doi-asserted-by":"publisher","first-page":"e2201978","DOI":"10.1002\/adma.202201978","volume":"34","author":"S Zhang","year":"2022","unstructured":"Zhang S, Li Z, Wang Q, Liu Q, Yuan W, Feng W, Li F. An NIR-II photothermally triggered \u201coxygen bomb\u201d for hypoxic tumor programmed cascade therapy. Adv Mater. 2022;34:e2201978.","journal-title":"Adv Mater"},{"key":"1765_CR18","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c09505","author":"F Zhuang","year":"2022","unstructured":"Zhuang F, Ma Q, Dong C, Xiang H, Shen Y, Sun P, Li C, Chen Y, Lu B, Chen Y, Huang B. Sequential ultrasound-triggered and hypoxia-sensitive nanoprodrug for cascade amplification of sonochemotherapy. ACS Nano. 2022. https:\/\/doi.org\/10.1021\/acsnano.1c09505.","journal-title":"ACS Nano"},{"key":"1765_CR19","doi-asserted-by":"publisher","first-page":"e2200139","DOI":"10.1002\/smtd.202200139","volume":"6","author":"J Yan","year":"2022","unstructured":"Yan J, Wang Y, Song X, Yan X, Zhao Y, Yu L, He Z. The advancement of gas-generating nanoplatforms in biomedical fields: current frontiers and future perspectives. Small Methods. 2022;6:e2200139.","journal-title":"Small Methods"},{"key":"1765_CR20","doi-asserted-by":"publisher","first-page":"e2200924","DOI":"10.1002\/smll.202200924","volume":"18","author":"V Pathak","year":"2022","unstructured":"Pathak V, Roemhild K, Schipper S, Gross-Weege N, Nolte T, Ruetten S, Buhl EM, El Shafei A, Weiler M, Martin L, et al. Theranostic trigger-responsive carbon monoxide-generating microbubbles. Small. 2022;18:e2200924.","journal-title":"Small"},{"key":"1765_CR21","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c02540","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Liu J, He M, Dong Q, Zhang L, Xu Z, Kang Y, Xue P. Platinum-titania schottky junction as nanosonosensitizer, glucose scavenger, and tumor microenvironment-modulator for promoted cancer treatment. ACS Nano. 2022. https:\/\/doi.org\/10.1021\/acsnano.2c02540.","journal-title":"ACS Nano"},{"key":"1765_CR22","doi-asserted-by":"publisher","first-page":"e2202921","DOI":"10.1002\/smll.202202921","volume":"18","author":"K Bian","year":"2022","unstructured":"Bian K, Yang W, Xu Y, Zeng W, Wang H, Liang H, Cui T, Wang Z, Zhang B. Specific-tuning band structure in hetero-semiconductor nanorods to match with reduction of oxygen molecules for low-intensity yet highly effective sonodynamic\/hole therapy of tumors. Small. 2022;18:e2202921.","journal-title":"Small"},{"key":"1765_CR23","doi-asserted-by":"publisher","first-page":"106090","DOI":"10.1016\/j.ultsonch.2022.106090","volume":"88","author":"M Aliabouzar","year":"2022","unstructured":"Aliabouzar M, Kripfgans OD, Estrada JB, Brian Fowlkes J, Fabiilli ML. Multi-time scale characterization of acoustic droplet vaporization and payload release of phase-shift emulsions using high-speed microscopy. Ultrason Sonochem. 2022;88:106090.","journal-title":"Ultrason Sonochem"},{"key":"1765_CR24","doi-asserted-by":"publisher","first-page":"105769","DOI":"10.1016\/j.ultsonch.2021.105769","volume":"79","author":"S Park","year":"2021","unstructured":"Park S, Son G. Numerical study of the effect of liquid compressibility on acoustic droplet vaporization. Ultrason Sonochem. 2021;79:105769.","journal-title":"Ultrason Sonochem"},{"key":"1765_CR25","doi-asserted-by":"publisher","first-page":"e2109969","DOI":"10.1002\/adma.202109969","volume":"34","author":"L Sun","year":"2022","unstructured":"Sun L, Zhou JE, Luo T, Wang J, Kang L, Wang Y, Luo S, Wang Z, Zhou Z, Zhu J, et al. Nanoengineered neutrophils as a cellular sonosensitizer for visual sonodynamic therapy of malignant tumors. Adv Mater. 2022;34:e2109969.","journal-title":"Adv Mater"},{"key":"1765_CR26","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1038\/s41467-019-09389-2","volume":"10","author":"W Wang","year":"2019","unstructured":"Wang W, Cheng Y, Yu P, Wang H, Zhang Y, Xu H, Ye Q, Yuan A, Hu Y, Wu J. Perfluorocarbon regulates the intratumoural environment to enhance hypoxia-based agent efficacy. Nat Commun. 2019;10:1580.","journal-title":"Nat Commun"},{"issue":"10","key":"1765_CR27","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1517\/17425247.2013.805742","volume":"10","author":"EO Blenke","year":"2013","unstructured":"Blenke EO, Mastrobattista E, Schiffelers RM. Strategies for triggered drug release from tumor targeted liposomes. Expert Opin Drug Deliv. 2013;10(10):1399\u2013410.","journal-title":"Expert Opin Drug Deliv"},{"key":"1765_CR28","doi-asserted-by":"publisher","first-page":"100299","DOI":"10.1016\/j.mtadv.2022.100299","volume":"16","author":"I Menon","year":"2022","unstructured":"Menon I, Zaroudi M, Zhang Y, Aisenbrey E, Hui L. Fabrication of active targeting lipid nanoparticles: challenges and perspectives. Mater Today Adv. 2022;16:100299.","journal-title":"Mater Today Adv"},{"key":"1765_CR29","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1021\/acs.nanolett.7b05087","volume":"18","author":"L Zhu","year":"2018","unstructured":"Zhu L, Zhao H, Zhou Z, Xia Y, Wang Z, Ran H, Li P, Ren J. Peptide-functionalized phase-transformation nanoparticles for low intensity focused ultrasound-assisted tumor imaging and therapy. Nano Lett. 2018;18:1831\u201341.","journal-title":"Nano Lett"},{"key":"1765_CR30","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s12951-021-00947-9","volume":"19","author":"J Wei","year":"2021","unstructured":"Wei J, Lei S, Meng A, Xun G, Chen C, Yuan L, Zhuo X, Xing W, Jun W, Shul L, et al. Amplifed antitumor efcacy by a targeted drug retention and chemosensitization strategy-based \u201ccombo\u201d nanoagent together with PD-L1 blockade in reversing multidrug resistance. J Nanobiotechnol. 2021;19:200.","journal-title":"J Nanobiotechnol"},{"key":"1765_CR31","doi-asserted-by":"publisher","first-page":"9355","DOI":"10.1021\/acsami.8b21968","volume":"11","author":"L Zhang","year":"2019","unstructured":"Zhang L, Yi H, Song J, Huang J, Yang K, Tan B, Wang D, Yang N, Wang Z, Li X. Mitochondria-targeted and ultrasound-activated nanodroplets for enhanced deep-penetration sonodynamic cancer therapy. ACS Appl Mater Interfaces. 2019;11:9355\u201366.","journal-title":"ACS Appl Mater Interfaces"},{"key":"1765_CR32","doi-asserted-by":"publisher","first-page":"4547","DOI":"10.2147\/IJN.S361648","volume":"17","author":"Y Luo","year":"2022","unstructured":"Luo Y, Qiao B, Yang C, Zhang P, Xie Z, Cao J, Yang A, Xiang Q, Ran H, Wang Z, et al. Low intensity focused ultrasound ignited \u201cdeep-penetration nanobomb\u201d (DPNB) for tetramodal imaging guided hypoxia-tolerant sonodynamic therapy against hypoxic tumors. Int J Nanomed. 2022;17:4547\u201365.","journal-title":"Int J Nanomed"},{"key":"1765_CR33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.bioactmat.2022.02.022","volume":"16","author":"J Hou","year":"2022","unstructured":"Hou J, Zhou J, Chang M, Bao G, Xu J, Ye M, Zhong Y, Liu S, Wang J, Zhang W, et al. LIFU-responsive nanomedicine enables acoustic droplet vaporization-induced apoptosis of macrophages for stabilizing vulnerable atherosclerotic plaques. Bioact Mater. 2022;16:120\u201333.","journal-title":"Bioact Mater"},{"key":"1765_CR34","doi-asserted-by":"publisher","first-page":"25757","DOI":"10.1364\/OE.401423","volume":"28","author":"T Liu","year":"2020","unstructured":"Liu T, Zhang X, Zhang H, Zhao H, Zhang Z, Tian Y. Method for monitoring singlet oxygen quantum yield in real time by time resolved spectroscopy measurement. Opt Express. 2020;28:25757\u201366.","journal-title":"Opt Express"},{"key":"1765_CR35","doi-asserted-by":"publisher","first-page":"15175","DOI":"10.1021\/acs.inorgchem.2c02374","volume":"61","author":"M Kou","year":"2022","unstructured":"Kou M, Qin F, Wang Y, Zhang X, Zhao H, Tian Y, Zhang Z. Intrinsic characterization method on the heavy atom effect of metalloporphyrins. Inorg Chem. 2022;61:15175\u201381.","journal-title":"Inorg Chem"},{"key":"1765_CR36","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1038\/s41467-022-32066-w","volume":"13","author":"W Wang","year":"2022","unstructured":"Wang W, Zheng H, Jiang J, Li Z, Jiang D, Shi X, Wang H, Jiang J, Xie Q, Gao M, et al. Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments. Nat Commun. 2022;13:4495.","journal-title":"Nat Commun"},{"key":"1765_CR37","doi-asserted-by":"publisher","first-page":"119576","DOI":"10.1016\/j.biomaterials.2019.119576","volume":"229","author":"J Wang","year":"2020","unstructured":"Wang J, Wang Z, Zhong Y, Zou Y, Wang C, Wu H, Lee A, Yang W, Wang X, Liu Y, et al. Central metal-derived co-assembly of biomimetic GdTPP\/ZnTPP porphyrin nanocomposites for enhanced dual-modal imaging-guided photodynamic therapy. Biomaterials. 2020;229:119576.","journal-title":"Biomaterials"},{"key":"1765_CR38","doi-asserted-by":"publisher","first-page":"6457","DOI":"10.1021\/acsnano.0c08848","volume":"15","author":"W Liu","year":"2021","unstructured":"Liu W, Xiang H, Tan M, Chen Q, Jiang Q, Yang L, Cao Y, Wang Z, Ran H, Chen Y. Nanomedicine enables drug-potency activation with tumor sensitivity and hyperthermia synergy in the second near-infrared biowindow. ACS Nano. 2021;15:6457\u201370.","journal-title":"ACS Nano"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01765-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-023-01765-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-023-01765-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T16:04:48Z","timestamp":1674662688000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-023-01765-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1765"],"URL":"https:\/\/doi.org\/10.1186\/s12951-023-01765-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]},"assertion":[{"value":"13 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest, including employment, consultancies, stock ownership, paid expert testimony, patent applications\/registrations, and grants or other funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}